Physician
Pathology
Dr. Howard M. Stern, MD
|
|
Give Review
Howard M. Stern, MD is an expert in the field of Pathology. He graduated from University of Washington School of Medicine. Howard Stern is a published MD. He has 28 papers published. The most current publication "PTEN loss is associated with worse outcome in HER2-amplified breast cancer patients but is not associated with trastuzumab resistance."
Publications
- PTEN loss is associated with worse outcome in HER2-amplified breast cancer patients but is not associated with trastuzumab resistance.
- Comparative Oncogenomics Identifies PSMB4 and SHMT2 as Potential Cancer Driver Genes.
- Oncogenic ERBB3 Mutations in Human Cancers.
- Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BC...
- Conditional activation of Pik3ca(H1047R) in a knock-in mouse model promotes mammary tumorigenesis and emergence of mutations.
- Proapoptotic activation of death receptor 5 on tumor endothelial cells disrupts the vasculature and reduces tumor growth.
- Analysis of Fcγ receptor IIIa and IIa polymorphisms: lack of correlation with outcome in trastuzumab-treated breast cancer patients.
- DNA Methylation Profiling Defines Clinically Relevant Biological Subsets of Non-small Cell Lung Cancer.
- PPM1H Is a p27 Phosphatase Implicated in Trastuzumab Resistance.
- miR-221/222 Targeting of Trichorhinophalangeal 1 (TRPS1) Promotes Epithelial-to-Mesenchymal Transition in Breast Cancer.
- TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer.
- Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab.
- Somatic mutations in p85alpha promote tumorigenesis through class IA PI3K activation.
- Oncogenic activating mutations are associated with local copy gain.
- Genetic alterations and oncogenic pathways associated with breast cancer subtypes.
- Construction and application of a zebrafish array comparative genomic hybridization platform.
- Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents.
- A central role for HER3 in HER2-amplified breast cancer: implications for targeted therapy.
- A mutation in separase causes genome instability and increased susceptibility to epithelial cancer.
- Oncogenic BRAF is required for tumor growth and maintenance in melanoma models.
- Small molecules that delay S phase suppress a zebrafish bmyb mutant.
- A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility.
- Effects of lethal irradiation in zebrafish and rescue by hematopoietic cell transplantation.
- Analysis of the cell cycle in zebrafish embryos.
- Zebrafish as a cancer model system.
- HSP90 Inhibition Enhances Antimitotic Drug-Induced Mitotic Arrest and Cell Death in Preclinical Models of Non-Small Cell Lung Cancer.
- Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer.
Schools
University Of Washington School Of Medicine
Bringham and Womens Hospital
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
University of Washington School of Medicine
Hospital
-
Brigham and Women's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Suzanne K. Coberly, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James H. Bainton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hyunseok P. Kang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donghui Lin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Weidong Huang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shirley J. Huang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Suba, MD
This Doctor is OpenDoctor Recommended.
|